Skip to Content
Merck
  • Laser Bioprinting of Cells Using UV and Visible Wavelengths: A Comparative DNA Damage Study.

Laser Bioprinting of Cells Using UV and Visible Wavelengths: A Comparative DNA Damage Study.

Bioengineering (Basel, Switzerland) (2022-08-26)
Panagiotis Karakaidos, Christina Kryou, Nikiana Simigdala, Apostolos Klinakis, Ioanna Zergioti
ABSTRACT

Laser-based techniques for printing cells onto different substrates with high precision and resolution present unique opportunities for contributing to a wide range of biomedical applications, including tissue engineering. In this study, laser-induced forward transfer (LIFT) printing was employed to rapidly and accurately deposit patterns of cancer cells in a non-contact manner, using two different wavelengths, 532 and 355 nm. To evaluate the effect of LIFT on the printed cells, their growth and DNA damage profiles were assessed and evaluated quantitatively over several days. The damaging effect of LIFT-printing was thoroughly investigated, for the first time at a single cell level, by counting individual double strand breaks (DSB). Overall, we found that LIFT was able to safely print patterns of breast cancer cells with high viability with little or no heat or shear damage to the cells, as indicated by unperturbed growth and negligible gross DNA damage.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Trypsin-EDTA solution, 0.25%, sterile-filtered, BioReagent, suitable for cell culture, 2.5 g porcine trypsin and 0.2 g EDTA, 4Na per liter of Hanks′ Balanced Salt Solution with phenol red
Sigma-Aldrich
Anti-phospho-H2A.X Antibody (Ser139), clone JBW301, Alexa Fluor 555 Conjugate, clone JBW301, from mouse, ALEXA FLUOR 555